Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery and Validation of Plasma Biomarkers for Major Depressive Disorder Classification Based on Liquid Chromatography–Mass Spectrometry
Xinyu Liu, Peng Zheng, Xinjie Zhao, et al.
Journal of Proteome Research (2015) Vol. 14, Iss. 5, pp. 2322-2330
Closed Access | Times Cited: 173

Showing 1-25 of 173 citing articles:

Quality assurance procedures for mass spectrometry untargeted metabolomics. a review
Danuta Dudzik, Cecilia Barbas-Bernardos, Antonia Garcı́a, et al.
Journal of Pharmaceutical and Biomedical Analysis (2017) Vol. 147, pp. 149-173
Closed Access | Times Cited: 307
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Lulu Cui, Shu Li, Siman Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 266
Metabolomics for the masses: The future of metabolomics in a personalized world
Drupad K. Trivedi, Katherine A. Hollywood, Royston Goodacre
European Journal of Molecular & Clinical Medicine (2017) Vol. 3, Iss. 6, pp. 294-294
Open Access | Times Cited: 176
The gut microbiome modulates gut–brain axis glycerophospholipid metabolism in a region-specific manner in a nonhuman primate model of depression
Peng Zheng, Jing Wu, Hanping Zhang, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 6, pp. 2380-2392
Open Access | Times Cited: 151
Recent advances in LC‐MS‐based metabolomics for clinical biomarker discovery
Chao‐Jung Chen, Der‐Yen Lee, Jiaxin Yu, et al.
Mass Spectrometry Reviews (2022) Vol. 42, Iss. 6, pp. 2349-2378
Closed Access | Times Cited: 84
From Complexity to Clarity: Expanding Metabolome Coverage With Innovative Analytical Strategies
Kanukolanu Aarika, Ramijinni Rajyalakshmi, Lakshmi Vineela Nalla, et al.
Journal of Separation Science (2025) Vol. 48, Iss. 2
Open Access | Times Cited: 3
Increased atherogenicity in mood disorders: a systematic review, meta-analysis and meta-regression
Ketsupar Jirakran, Abbas F. Almulla, Thapanee Jaipinta, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 169, pp. 106005-106005
Closed Access | Times Cited: 2
Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents
Xinyu Zhou, Lanxiang Liu, Xinghui Lan, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 10, pp. 1478-1488
Open Access | Times Cited: 149
Plasma lipidomics reveals potential lipid markers of major depressive disorder
Xinyu Liu, Jia Li, Peng Zheng, et al.
Analytical and Bioanalytical Chemistry (2016) Vol. 408, Iss. 23, pp. 6497-6507
Closed Access | Times Cited: 123
From peroxisomal disorders to common neurodegenerative diseases – the role of ether phospholipids in the nervous system
Fabian Dorninger, Sonja Forss‐Petter, Johannes Berger
FEBS Letters (2017) Vol. 591, Iss. 18, pp. 2761-2788
Open Access | Times Cited: 118
Plasma Metabolites Predict Severity of Depression and Suicidal Ideation in Psychiatric Patients-A Multicenter Pilot Analysis
Daiki Setoyama, Takahiro A. Kato, Ryota Hashimoto, et al.
PLoS ONE (2016) Vol. 11, Iss. 12, pp. e0165267-e0165267
Open Access | Times Cited: 109
Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies
Yu Han, Jianjun Chen, Dezhi Zou, et al.
Neuropsychiatric Disease and Treatment (2016) Vol. Volume 12, pp. 2859-2867
Open Access | Times Cited: 105
Altered gut metabolome contributes to depression-like behaviors in rats exposed to chronic unpredictable mild stress
Jianguo Li, Jia Xueyang, Cui Wang, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 104
Effects of gut microbiota on the microRNA and mRNA expression in the hippocampus of mice
Jianjun Chen, Benhua Zeng, Wenwen Li, et al.
Behavioural Brain Research (2017) Vol. 322, pp. 34-41
Closed Access | Times Cited: 100
Biomarkers of Post-COVID Depression
Piotr Lorkiewicz, Napoleon Waszkiewicz
Journal of Clinical Medicine (2021) Vol. 10, Iss. 18, pp. 4142-4142
Open Access | Times Cited: 92
The identification of metabolic disturbances in the prefrontal cortex of the chronic restraint stress rat model of depression
Lanxiang Liu, Xinyu Zhou, Yuqing Zhang, et al.
Behavioural Brain Research (2016) Vol. 305, pp. 148-156
Closed Access | Times Cited: 91
IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity
Adriano José Maia Chaves Filho, Camila Nayane de Carvalho Lima, Silvânia Maria Mendes Vasconcelos, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 80, pp. 234-249
Open Access | Times Cited: 89
Depression: Biological markers and treatment
Gordana Nedić Erjavec, Marina Šagud, Matea Nikolac Perković, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 105, pp. 110139-110139
Closed Access | Times Cited: 88
Cholesterol and triglyceride levels in first-episode patients with major depressive disorder: A meta-analysis of case-control studies
Yange Wei, Dong-Bin Cai, Juan Liu, et al.
Journal of Affective Disorders (2020) Vol. 266, pp. 465-472
Closed Access | Times Cited: 73
Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression
Siamak MahmoudianDehkordi, Ahmed T. Ahmed, Sudeepa Bhattacharyya, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 71
Lipid Alteration Signature in the Blood Plasma of Individuals With Schizophrenia, Depression, and Bipolar Disorder
Anna Tkachev, Elena Stekolshchikova, Anna Vanyushkina, et al.
JAMA Psychiatry (2023) Vol. 80, Iss. 3, pp. 250-250
Closed Access | Times Cited: 32
A review of validated biomarkers obtained through metabolomics
Ángeles López-López, Ángeles López‐Gonzálvez, Tomás Clive Barker‐Tejeda, et al.
Expert Review of Molecular Diagnostics (2018) Vol. 18, Iss. 6, pp. 557-575
Closed Access | Times Cited: 83
Targeted Metabolomic Pathway Analysis and Validation Revealed Glutamatergic Disorder in the Prefrontal Cortex among the Chronic Social Defeat Stress Mice Model of Depression
Wei Wang, Hua Guo, Shu‐Xiao Zhang, et al.
Journal of Proteome Research (2016) Vol. 15, Iss. 10, pp. 3784-3792
Closed Access | Times Cited: 74
Correction: Altered gut metabolome contributes to depression-like behaviors in rats exposed to chronic unpredictable mild stress
Jianguo Li, Jia Xueyang, Cui Wang, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 71
Differential urinary metabolites related with the severity of major depressive disorder
Jianjun Chen, Chanjuan Zhou, Peng Zheng, et al.
Behavioural Brain Research (2017) Vol. 332, pp. 280-287
Closed Access | Times Cited: 69
Page 1 - Next Page

Scroll to top